Literature DB >> 25764176

"Seek, test, treat and retain" for hepatitis C in the United States criminal justice system.

Sarah Larney1, Curt G Beckwith, Nickolas D Zaller, Brian T Montague, Josiah Rich.   

Abstract

PURPOSE: The purpose of this paper is to consider the potential benefits and challenges of applying a strategy of "seek, test, treat and retain" (STTR) to hepatitis C virus (HCV) in the US criminal justice system. DESIGN/METHODOLOGY/APPROACH: The authors draw on the published literature to illustrate how each component of STTR could be applied to HCV in the US criminal justice system, and describe challenges to the implementation of this strategy.
FINDINGS: The burden of morbidity and mortality associated with chronic HCV infection in the USA is increasing and without significantly increased treatment uptake, will likely continue to do so for several decades. The authors argue that the US criminal justice system is an ideal focus for HCV case finding and treatment due to a high prevalence of infection and large volume of individuals in contact with this system. STTR would identify large numbers of HCV infections, leading to opportunities for secondary prevention and primary care. Important challenges to the implementation of STTR include treatment costs and training of prison medical providers. ORIGINALITY/VALUE: This paper highlights opportunities to address HCV in the US criminal justice system.

Entities:  

Keywords:  Criminal justice system; Hepatitis C; Prisoners

Mesh:

Substances:

Year:  2014        PMID: 25764176      PMCID: PMC4358744          DOI: 10.1108/IJPH-11-2013-0051

Source DB:  PubMed          Journal:  Int J Prison Health        ISSN: 1744-9200


  38 in total

1.  New opportunities for the management and therapy of hepatitis C in correctional settings.

Authors:  C Kent Martin; Jeffrey E Hostetter; John J Hagan
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

2.  A missed opportunity: hepatitis C screening of prisoners.

Authors:  Grace E Macalino; Darpun Dhawan; Josiah D Rich
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

3.  Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting.

Authors:  Sergio Sabbatani; Ruggero Giuliani; Roberto Manfredi
Journal:  Braz J Infect Dis       Date:  2006-08       Impact factor: 1.949

Review 4.  Epidemiology of hepatitis B and C viruses: a global overview.

Authors:  Helen S Te; Donald M Jensen
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

5.  Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C.

Authors:  Kara W Chew; Scott A Allen; Lynn E Taylor; Josiah D Rich; Edward Feller
Journal:  J Clin Gastroenterol       Date:  2009-08       Impact factor: 3.062

Review 6.  Treating hepatitis C in the prison population is cost-saving.

Authors:  Jennifer A Tan; Tom A Joseph; Sammy Saab
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

7.  Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention.

Authors:  Cindy Weinbaum; Rob Lyerla; Harold S Margolis
Journal:  MMWR Recomm Rep       Date:  2003-01-24

8.  End-stage liver disease in a state prison population.

Authors:  Jacques Baillargeon; Roger D Soloway; David Paar; Thomas P Giordano; Owen Murray; James Grady; Brie Williams; John Pulvino; Ben G Raimer
Journal:  Ann Epidemiol       Date:  2007-08-06       Impact factor: 3.797

9.  Accessing antiretroviral therapy following release from prison.

Authors:  Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

10.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

View more
  8 in total

1.  Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle.

Authors:  Judith I Tsui; Claire M Miller; John D Scott; Maria A Corcorran; Julia C Dombrowski; Sara N Glick
Journal:  Drug Alcohol Depend       Date:  2018-12-26       Impact factor: 4.492

2.  A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections.

Authors:  Curt G Beckwith; Ann E Kurth; Lauri B Bazerman; Emily J Patry; Alice Cates; Liem Tran; Amanda Noska; Irene Kuo
Journal:  J Public Health (Oxf)       Date:  2015-03-02       Impact factor: 2.341

Review 3.  Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.

Authors:  Josiah D Rich; Curt G Beckwith; Alexandria Macmadu; Brandon D L Marshall; Lauren Brinkley-Rubinstein; Joseph J Amon; M-J Milloy; Maximilian R F King; Jorge Sanchez; Lukoye Atwoli; Frederick L Altice
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

4.  Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system.

Authors:  Justin C Strickland; Michele Staton; Carl G Leukefeld; Carrie B Oser; J Matthew Webster
Journal:  Int J Prison Health       Date:  2018-06-11

5.  New hepatitis C virus infection, re-infection and associated risk behaviour in male Irish prisoners: a cohort study, 2019.

Authors:  Des Crowley; Gordana Avramovic; Walter Cullen; Collette Farrell; Anne Halpin; Mary Keevans; Eamon Laird; Tina McHugh; Susan McKiernan; Sarah Jayne Miggin; Ross Murtagh; Eileen O Connor; Marie O'Meara; Deirdre O Reilly; John S Lambert
Journal:  Arch Public Health       Date:  2021-06-08

6.  Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.

Authors:  Desmond Crowley; Ross Murtagh; Walter Cullen; Mary Keevans; Eamon Laird; Tina McHugh; Susan McKiernan; Sarah Jayne Miggin; Eileen O'Connor; Deirdre O'Reilly; Graham Betts-Symonds; Ciara Tobin; Marie Claire Van Hout; John S Lambert
Journal:  Harm Reduct J       Date:  2019-07-05

7.  CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.

Authors:  Sarah Schillie; Carolyn Wester; Melissa Osborne; Laura Wesolowski; A Blythe Ryerson
Journal:  MMWR Recomm Rep       Date:  2020-04-10

8.  A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.

Authors:  Dana Busschots; Cécile Kremer; Rob Bielen; Özgür M Koc; Leen Heyens; Christian Brixko; Pierre Laukens; Hans Orlent; Pascal Bilaey; Francis De Smet; Geert Hellemans; Gaetan Muyldermans; Luk Van Baelen; Niel Hens; Hans Van Vlierberghe; Geert Robaeys
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.